Medicine & Health

In 2025, the WashU community made new discoveries, celebrated new victories and launched new efforts to make the globe safer and healthier. 

A team of WashU researchers has integrated two novel vision-language models that create a potential AI assistant that may help people with cognitive decline cook meals and remain independent.

Researchers at Washington University in St. Louis have investigated how assemblies of molecules called microphases could be a useful target in developing treatments for neurodegenerative disorders.

Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the bone marrow. The new resource could improve prognosis and guide development of new immunotherapies.

A team led by Yan Yu of Washington University in St. Louis developed a double-pronged approach to fighting antibiotic resistance.

Startups built on WashU discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices.

In a new study, WashU Medicine researchers found that widely prescribed drugs such as Ritalin and Adderall don’t affect attention-controlling regions of the brain, as previously thought, but rather act on areas involved in wakefulness and reward.

Long-term use of a new drug, toferson, approved by the FDA for a rare genetic form of ALS, delays symptom progression and death and leads to stabilization or improvement in some patients, according to a study by WashU Medicine researchers and collaborators.

Researchers at Washington University in St. Louis have found a way to better track circadian brain signals that synchronize the body clocks.

Analysis spanning 16 nations finds households integrated into communities build jobs, savings and stability over time.